|星空彩票电脑版
%A DU Guan-hua，ZHANG Wen，DU Li-da，MA Yin-zhong，LI Li，WANG Yue-hua %T
New Strategies for the Drug Development of Anti-cerebral Ischemia
—Advances in the Etiology and Drug Development of Acute Cerebral Ischemia %0 Journal Article %D 2018 %J ACTA NEUROPHARMACOLOGICA %R 10.3969/j.issn.2095-1396.2018.01.001 %P 1-8 %V 8 %N 1 %U {http://actanp.hebeinu.edu.cn/CN/abstract/article_510.shtml} %8 2018-02-26 %X Acute cerebral ischemia （stroke） is a major disease which threat to people’s health because of its high incidence，high mortality and high morbidity. Of particular concern is that the clinical application of a serious lack of prevention and treatment of drugs，and a large number of research and development of drugs has not been successful. This paper analyzes the current status of prevention and treatment of acute cerebral ischemia drugs and the reasons for its lack of success. It is proposed that a new strategy is necessary for new drug development and research. Based on the recognization of the analysis of the disease pathology and drug research，we suggested the disease pathogenesis and features based strategy and pathological process based drug development strategies.